Evidence receipt / recommendation
Published · transcript-backedMentions personal use of Alex.
22 Jan 2024 Acquired Novo Nordisk (Ozempic)
“I think that helped frame my understanding of how we got here in drug development better than really anything else I read, so thanks Alex for that too.”
Source trail
Everything needed to verify it.
- Speaker
- Ben Gilbert
- Attribution
- Verified speaker
- Claim type
- recommendation
- Recorded
- 22 Jan 2024
- Publisher
- Acquired
- Episode
- Novo Nordisk (Ozempic)
Transcript context
…Yeah, Tom is great. Some blog posts from the Drug Channels Institute that were publicly available, that I thought were great, some very helpful DMs with Ashwin Varma, who pointed me to a lot of the great information about the profitability, frankly lack thereof, or the returns on invested capital for pharma industry. He's actually a med school student and former Lux Capital associate, so he's got a foot in both the capitalist and the medical camps. And a truly incredible long form read on Github by Alex Telford. I think that helped frame my understanding of how we got here in drug development better than really anything else I read, so thanks Alex for that too. Sign up for notifications of when new episodes drop, acquired.fm/email. You can also get our follow ups, the corrections, and teasers at what the next episode will be. ACQ2, you should go check it out. It is where we do follow up interviews when we have topics we're more interested in. Perhaps we'll do that for healthcare or just CEOs or investors that we want to talk to. Look in any podcast player. After you finish this episode, come discuss it with us at acquired.fm/slack. If you want any of that sweet Acquired merch, go to acquired.fm/store. In fact, I am wearing the t-shirt now, so check it out. With that, listeners, we'll see you next time. We'll see you next time.…
Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.
Named in this claim